Literature DB >> 35441721

TRPV4: En RhoA To a Cure?

Qun Lu1,2, Yan-Hua Chen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35441721      PMCID： PMC9191820          DOI： 10.1002/bies.202200071

Source DB:  PubMed          Journal:  Bioessays        ISSN： 0265-9247            Impact factor:   4.653


× No keyword cloud information.
  4 in total

1.  Interaction of p190RhoGAP with C-terminal domain of p120-catenin modulates endothelial cytoskeleton and permeability.

Authors:  Noureddine Zebda; Yufeng Tian; Xinyong Tian; Grzegorz Gawlak; Katherine Higginbotham; Albert B Reynolds; Anna A Birukova; Konstantin G Birukov
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

2.  Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases.

Authors:  William Guiler; Addison Koehler; Christi Boykin; Qun Lu
Journal:  Front Cell Neurosci       Date:  2021-05-12       Impact factor: 5.505

3.  TRPV4: A trigger of pathological RhoA activation in neurological disease.

Authors:  Anna M Bagnell; Charlotte J Sumner; Brett A McCray
Journal:  Bioessays       Date:  2022-03-17       Impact factor: 4.653

4.  Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies.

Authors:  Kevin C Tran; Anne Y Zeng; Tao Yang; Stephen M Massa; Frank M Longo
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.996
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.